AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34237655 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 509
Study 34617955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant-Palbociclib
Number of subjects: 486
Study 34617955 — intervention group
Group type: COMPARATOR
Intervention: Letrozole-Palbociclib
Number of subjects: 486
Study 32478616 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 cm shoe lift on the non-affected lower limb
Number of subjects: 42
Study 32478616 — intervention group
Group type: COMPARATOR
Intervention: No shoe lift
Number of subjects: 42
Study 33799341 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic compression of the first dorsal interosseous muscle trigger points (MTrPs)
Number of subjects: 31
Study 33799341 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment of the first dorsal interosseous muscle trigger points (MTrPs)
Number of subjects: 31
Study 34867113 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention for 2 months on top of routine intervention
Number of subjects: 100
Study 34867113 — intervention group
Group type: COMPARATOR
Intervention: Routine radiotherapy and chemotherapy with routine nursing intervention
Number of subjects: 100
Study 32563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine with MPL
Number of subjects: 294
Study 32563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine without MPL
Number of subjects: 294
Study 32563606 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one dose)
Number of subjects: 294
Study 32563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine (one dose)
Number of subjects: 294
Study 32563606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine (two doses)
Number of subjects: 294
Study 34698676 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical thoracoscopy (MT)
Number of subjects: 0
Study 34698676 — intervention group
Group type: COMPARATOR
Intervention: Rigid mini-thoracoscopy
Number of subjects: 0
Study 34698676 — intervention group
Group type: COMPARATOR
Intervention: Pleural cryobiopsy
Number of subjects: 0
Study 34551681 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention group (oral presentation by CPCC and distribution of gift packages)
Number of subjects: 336
Study 34551681 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 336
Study 33186448 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthostatic Hypotension (OH)
Number of subjects: 897
Study 32195749 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits for secondary distribution offered to individuals aged 18 years and older.
Number of subjects: 9105
Study 32195749 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits for secondary distribution.
Number of subjects: 9105
Study 36129712 — intervention group
Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile intervention (21 online psychoeducational and skill-building modules over 3 months)
Number of subjects: 763
Study 36129712 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (access to MyPEEPS Mobile at 9-month visit)
Number of subjects: 763
Study 36129712 — intervention group
Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile intervention
Number of subjects: 763
Study 32674126 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on day 1 followed by 400 mg once daily for 6 days
Number of subjects: 293
Study 32674126 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 293
Study 32153050 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine 10% spray
Number of subjects: 0
Study 32153050 — intervention group
Group type: COMPARATOR
Intervention: Oral dapoxetine 60 mg
Number of subjects: 0
Study 33901635 — intervention group
Group type: EXPERIMENTAL
Intervention: C/N 15:1 bioflocs
Number of subjects: 360
Study 33901635 — intervention group
Group type: COMPARATOR
Intervention: C/N 20:1 bioflocs
Number of subjects: 360
Study 33901635 — intervention group
Group type: COMPARATOR
Intervention: Commercial diet (control)
Number of subjects: 360
Study 33583424 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based decision aid on relapse management, nurse-led webinar, and access to a monitored chat forum
Number of subjects: 188
Study 33583424 — intervention group
Group type: COMPARATOR
Intervention: Standard information via the same online platform
Number of subjects: 188
Study 36368240 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory unloader knee orthosis
Number of subjects: 14
Study 36368240 — intervention group
Group type: COMPARATOR
Intervention: Conventional knee orthosis
Number of subjects: 14
Study 34463398 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter therapy applied twice a week for 4 weeks
Number of subjects: 61
Study 34463398 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 61
Study 32977565 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed energy supply algorithm based on matching game and convex optimization
Number of subjects: 0
Study 35697040 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab or nivolumab
Number of subjects: 77
Study 35697040 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonautoimmune patients)
Number of subjects: 77
Study 35697040 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoimmune group
Number of subjects: 77
Study 35697040 — intervention group
Group type: COMPARATOR
Intervention: Nonautoimmune group
Number of subjects: 77
Study 34375320 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite chip bone (Group A)
Number of subjects: 97
Study 34375320 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogenic chip bone (Group B)
Number of subjects: 97
Study 34375320 — intervention group
Group type: COMPARATOR
Intervention: No bone graft (Group C)
Number of subjects: 97
Study 32917221 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v (Sanprobi IBS®)
Number of subjects: 40
Study 32917221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum feeding without calcium salts of palm oil (ANF)
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum feeding with calcium salts of palm oil (AWF)
Number of subjects: 60
Study 35830482 — intervention group
Group type: COMPARATOR
Intervention: Restricted feeding without calcium salts of palm oil (RNF)
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted feeding with calcium salts of palm oil (RWF)
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum feeding after restriction
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma GIP concentration
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of GIP with RQ
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin correlation with GIP and RQ
Number of subjects: 60
Study 35830482 — intervention group
Group type: EXPERIMENTAL
Intervention: Association between GIP and marbling score (MS)
Number of subjects: 60
Study 34479761 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen plaster 30 mg twice daily (n = 118)
Number of subjects: 236
Study 34479761 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac plaster 15 mg once daily (n = 118)
Number of subjects: 236
Study 34479761 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen plaster 30 mg twice daily
Number of subjects: 236
Study 34479761 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac plaster 15 mg once daily
Number of subjects: 236
Study 34479761 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Injury and Osteoarthritis Outcome Score
Number of subjects: 236
Study 34479761 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of rescue medication use
Number of subjects: 236
Study 34479761 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse event profile
Number of subjects: 236
Study 36018846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment and Intervention (EMAI) using a smartphone-based application over a 90-day period.
Number of subjects: 50
Study 36018846 — intervention group
Group type: COMPARATOR
Intervention: Ecological Momentary Assessment (EMA)
Number of subjects: 50
Study 34099584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat load (150 g of fat at time 0)
Number of subjects: 8
Study 34099584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat load with fructose (three doses of 50 g at 0, 2, and 4 hours)
Number of subjects: 8
Study 34099584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat load with glucose (three doses of 50 g at 0, 2, and 4 hours)
Number of subjects: 8
Study 34099584 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 8
Study 32827709 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loading (IRL) at 15 cmH2O
Number of subjects: 9
Study 32827709 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (CON)
Number of subjects: 9
Study 34968821 — intervention group
Group type: EXPERIMENTAL
Intervention: Information received from health professionals (face to face through childbirth education or midwife discussion/education)
Number of subjects: 1034
Study 34968821 — intervention group
Group type: EXPERIMENTAL
Intervention: Information from friends and family members
Number of subjects: 1034
Study 34968821 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet as a source of information
Number of subjects: 1034
Study 34968821 — intervention group
Group type: EXPERIMENTAL
Intervention: Trusted and reliable sources of information
Number of subjects: 1034
Study 34367541 — intervention group
Group type: EXPERIMENTAL
Intervention: BPNN artificial intelligence algorithm for ultrasound image segmentation
Number of subjects: 90
Study 34367541 — intervention group
Group type: COMPARATOR
Intervention: Routine ultrasound diagnosis
Number of subjects: 90
Study 34367541 — intervention group
Group type: EXPERIMENTAL
Intervention: BPNN artificial intelligence algorithm
Number of subjects: 90
Study 36269938 — intervention group
Group type: EXPERIMENTAL
Intervention: HepB-CpG (HEPLISAV-B®)
Number of subjects: 155
Study 36269938 — intervention group
Group type: COMPARATOR
Intervention: HepB-Eng (Engerix-B®)
Number of subjects: 155
Study 36269938 — intervention group
Group type: COMPARATOR
Intervention: HepB-AS04 (Fendrix®)
Number of subjects: 155
Study 32808736 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal septal myocardial ablation (PTSMA)
Number of subjects: 10
Study 32808736 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 10
Study 33084335 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich foods
Number of subjects: 0
Study 35673850 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal infant-directed reading intervention
Number of subjects: 67
Study 35673850 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 67
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: FM50Fu diet group (fucoidan supplemented with 50% FM replacement)
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: FM25Fu diet group (fucoidan supplemented with 25% FM replacement)
Number of subjects: 3
Study 33033967 — intervention group
Group type: COMPARATOR
Intervention: FM-based control diet (FM diet)
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: FM75 diet group (75% FM replacement, no fucoidan)
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented groups (D2, D3, D4, D5, D6, D7)
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented diets
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented groups
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: FM75Fu diet group (fucoidan supplemented with 75% FM replacement)
Number of subjects: 3
Study 33033967 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction effects of fucoidan and FM replacement level
Number of subjects: 3
Study 36029465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263
Study 33952245 — intervention group
Group type: EXPERIMENTAL
Intervention: Group behavior therapy knowledge, attitude, and beliefs assessment
Number of subjects: 229
Study 33952245 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous attempts to quit smoking
Number of subjects: 229
Study 33952245 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of cigarettes used per day
Number of subjects: 229
Study 33952245 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of education
Number of subjects: 229
Study 33892671 — intervention group
Group type: EXPERIMENTAL
Intervention: EPIC program (intervention with peer recovery supporter, family treatment drug court, medications for opioid use disorders, home-based parenting supports)
Number of subjects: 750
Study 33892671 — intervention group
Group type: EXPERIMENTAL
Intervention: EPIC program (intervention)
Number of subjects: 750
Study 33892671 — intervention group
Group type: COMPARATOR
Intervention: Comparison groups (Ohio START and treatment as usual)
Number of subjects: 750
Study 32643884 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation with bilateral scalp acupuncture
Number of subjects: 84
Study 32643884 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture based on acupoint selection for pseudobulbar palsy (Control)
Number of subjects: 84
Study 35613385 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy-free diet for mothers during the first 14 days after the newborn's onset of feeding
Number of subjects: 120
Study 35613385 — intervention group
Group type: COMPARATOR
Intervention: No special diet given to mothers
Number of subjects: 120
Study 33150514 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal trans-cranial direct current stimulation (a-tDCS) + Functional Electrical Stimulation (FES)
Number of subjects: 32
Study 33150514 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + Functional Electrical Stimulation (FES)
Number of subjects: 32
Study 33150514 — intervention group
Group type: COMPARATOR
Intervention: Control group (20-min FES only)
Number of subjects: 32
Study 32962055 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 0
Study 32962055 — intervention group
Group type: COMPARATOR
Intervention: Episiotomy
Number of subjects: 0
Study 32962055 — intervention group
Group type: COMPARATOR
Intervention: No perineal tears
Number of subjects: 0
Study 32962055 — intervention group
Group type: COMPARATOR
Intervention: Greater parity
Number of subjects: 0
Study 34018031 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training) group attended sessions three days per week for eight weeks.
Number of subjects: 30
Study 34018031 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained current level of physical activity.
Number of subjects: 30
Study 32813610 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelarabine
Number of subjects: 1562
Study 32813610 — intervention group
Group type: COMPARATOR
Intervention: No nelarabine
Number of subjects: 1562
Study 32813610 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MTX plus nelarabine
Number of subjects: 1562
Study 35332811 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced treadmill walking
Number of subjects: 25
Study 35332811 — intervention group
Group type: COMPARATOR
Intervention: Overground walking
Number of subjects: 25
Study 34884273 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenar-On group (active treatment)
Number of subjects: 60
Study 34884273 — intervention group
Group type: COMPARATOR
Intervention: Scenar-Off group (sham treatment)
Number of subjects: 60
Study 34884273 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34658139 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel containing 5% onion extract
Number of subjects: 0
Study 34658139 — intervention group
Group type: COMPARATOR
Intervention: Silicone gel containing vitamin C (Control)
Number of subjects: 0
Study 34037282 — intervention group
Group type: EXPERIMENTAL
Intervention: palbociclib (125 mg/day, 3/1 schedule)–fulvestrant (500 mg, intramuscular injection)
Number of subjects: 521
Study 34037282 — intervention group
Group type: COMPARATOR
Intervention: placebo-fulvestrant
Number of subjects: 521
Study 36231171 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Education Therapy (PET) group (n = 24)
Number of subjects: 50
Study 36231171 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) (n = 26)
Number of subjects: 50
Study 33627290 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus plane block (SPB)
Number of subjects: 30
Study 32340738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold application for 20 minutes
Number of subjects: 105
Study 32340738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold application for 30 minutes
Number of subjects: 105
Study 35986170 — intervention group
Group type: COMPARATOR
Intervention: Traditional dysphagia therapy (TDT)
Number of subjects: 34
Study 35986170 — intervention group
Group type: EXPERIMENTAL
Intervention: TDT with neuromuscular electrical stimulation (NMES)
Number of subjects: 34
Study 33722875 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA), initiated prehospital and continued in hospital over 8 hours
Number of subjects: 1316
Study 33722875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1316
Study 33722875 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 1316
Study 34056000 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle laparoscopic operation
Number of subjects: 180
Study 34056000 — intervention group
Group type: COMPARATOR
Intervention: Traditional laparoscopic operation
Number of subjects: 180
Study 34056000 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study 33035202 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transforaminal endoscopic decompression (PTED)
Number of subjects: 188
Study 33035202 — intervention group
Group type: COMPARATOR
Intervention: Fenestration
Number of subjects: 188
Study 33035202 — intervention group
Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 188
Study 35253163 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises plus conventional PT program
Number of subjects: 34
Study 35253163 — intervention group
Group type: COMPARATOR
Intervention: Standard PT program
Number of subjects: 34
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine use
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical aggression toward partners (PA-P)
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical aggression toward non-partners (PA-NP)
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical injury of partners (PI-P)
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical injury of non-partners (PI-NP)
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia moderating cocaine use and PA-NP
Number of subjects: 762
Study 34022495 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia and violence prediction
Number of subjects: 762
Study 32155105 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese radiologists
Number of subjects: 424
Study 32155105 — intervention group
Group type: EXPERIMENTAL
Intervention: U.S. radiologists
Number of subjects: 424
Study 32155105 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 pneumonia
Number of subjects: 424
Study 36220625 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM tool used in encounters
Number of subjects: 922
Study 36220625 — intervention group
Group type: COMPARATOR
Intervention: Usual care encounters
Number of subjects: 922
Study 36220625 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM tool exposure
Number of subjects: 922
Study 34259433 — intervention group
Group type: EXPERIMENTAL
Intervention: povidone iodine
Number of subjects: 32
Study 34259433 — intervention group
Group type: EXPERIMENTAL
Intervention: hydrogen peroxide
Number of subjects: 32
Study 34259433 — intervention group
Group type: COMPARATOR
Intervention: benzethonium chloride
Number of subjects: 32
Study 34259433 — intervention group
Group type: COMPARATOR
Intervention: tap water
Number of subjects: 32
Study 35922794 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal Ginkgo biloba extract (Ginkgosome™)
Number of subjects: 13
Study 35922794 — intervention group
Group type: COMPARATOR
Intervention: Comparator formulation of Ginkgo biloba extract
Number of subjects: 13
Study 33650630 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 323
Study 33650630 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 323
Study 32438401 — intervention group
Group type: COMPARATOR
Intervention: Milk protein (31 g, 26.2 g protein: 2.5 g leucine)
Number of subjects: 20
Study 32438401 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycoprotein (70 g, 31.5 g protein: 2.5 g leucine)
Number of subjects: 20
Study 34137291 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (no AP)
Number of subjects: 421
Study 34137291 — intervention group
Group type: COMPARATOR
Intervention: 2-year antibiotic prophylaxis (2-y AP)
Number of subjects: 421
Study 34137291 — intervention group
Group type: COMPARATOR
Intervention: Lifetime antibiotic prophylaxis (lifetime AP)
Number of subjects: 421
Study 34544205 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily for 3 months
Number of subjects: 74
Study 34544205 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 74
Study 35248295 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute pegboard and ring test (6PBRT)
Number of subjects: 0